Urology

Value-based Imaging in Early Prostate Cancer Staging

American College of Radiology

Activity Information and Disclosures

Published Online: June 1, 2015 R-SCAN Value-based Imaging Audio 14 min 1 sec

Audio Information

Authors:

Steven Eberhardt, MD, Professor and Vice Chair of Clinical Operations, Chief of Oncologic Imaging, Department of Radiology, University of New Mexico Health Sciences Center, University of New Mexico, Comprehensive Cancer Center

Thomas M. Schroeder, MD, Associate Director, Director of Radiation Oncology, Department of Medicine, University of New Mexico Health Sciences Center, University of New Mexico, Comprehensive Cancer Center

Designation Statement: The American College of Radiology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. You must achieve a minimum score of 80% to receive credit. Estimated time to complete the enduring material is 30 minutes.

Only physicians are eligible to be awarded AMA PRA Category 1 Credit™. The AMA defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country.

Statement of Competency: This activity is designed to address the following ABMS/ACGME competencies: interpersonal & communication skills and medical knowledge.

Accreditation Statement: The American College of Radiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Disclosure Statement: In compliance with ACCME requirements and guidelines, the ACR has developed a policy for review and disclosure of potential conflicts of interest, and a method of resolution if a conflict does exist. The ACR maintains a tradition of scientific integrity and objectivity in its educational activities. In order to preserve this integrity and objectivity, all individuals participating as planners, presenters, moderators, and evaluators in an ACR educational activity or an activity jointly sponsored by the ACR must appropriately disclose any financial relationship with a commercial organization that may have an interest in the content of the educational activity.

The following faculty indicated that they have no relevant financial relationships related to the presentation of this material:

Steven Eberhardt, MD

Thomas M. Schroeder, MD

ACR staff have indicated that they have no relevant financial relationships related to this educational activity.

Renewal Date: June 1, 2019

References

Eberhardt SC, Carter S, Casalino DD, et al. ACR appropriateness criteria prostate cancer—pretreatment detection, staging, and surveillance. JACR. 2013:10(2):83–92.Google Scholar

Abuzallouf S, Dayes I, Lukka H. Baseline staging of newly diagnosed prostate cancer: a summary of the literature. The Journal of Urology. 2004;171(6):2122–2127.Google Scholar

Lavery HJ, Brajtbord JS, Levinson AW, Nabizada-Pace F, Pollard ME, Samadi DB. Unnecessary imaging for the staging of low-risk prostate cancer is common. Urology. 2011;77(2):274–278.Google Scholar

Guo R, Cai L, Fan Y, Jin J, Zhou L, Zhang K. Magnetic resonance imaging on disease reclassification among active surveillance candidates with low-risk prostate cancer: a diagnostic meta-analysis. Prostate Cancer and Prostatic Diseases. 2015;18(3):221–228.Google Scholar

Mullins JK, Bonekamp D, Landis P, et al. Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance. BJU International. 2013:111(7);1037–1045.Google Scholar

Augustin H, Fritz GA, Ehammer T, Auprich M, Pummer K. Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the Partin tables. Acta Radiol. 2009;50(5):562–569.Google Scholar

Bloch BN, Furman-Haran E, Helbich TH, et al. Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging—initial results. Radiology. 2007;245(1):176–185.Google Scholar

Hricak H, Wang L, Wei DC, et al. The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer. 2004;100(12):2655–2663.Google Scholar

Huncharek M, Muscat J. Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer. Cancer Investigation. 1995;13(1):31–35.Google Scholar

10.

Özgür BC, Gültekin S, Ekici M, Yılmazer D, Alper M. A narrowing range of bone scan in newly diagnosed prostate cancer patients: A retrospective comparative study. Urology Annals. 2015;7(2):193.Google Scholar

11.

Gandaglia G, Abdollah F, Schiffmann J, et al. Distribution of metastatic sites in patients with prostate cancer: a population-based analysis. Prostate. 2014;74(2):210–216.Google Scholar

12.

Risko R, Merdan S, Womble PR, et al. Clinical predictors and recommendations for staging computed tomography scan among men with prostate cancer. Urology. 2014;84(6):1329–1334.Google Scholar

Value-based Imaging in Early Prostate Cancer Staging

Value-Based Patient-Centered Care

AMA Membership provides:

Sign in to access

Sign in to customize your interests

Name Your Search

Sign in to save your search

Lookup An Activity

My Saved Searches

My Saved Courses

Purchase access